Related to this topic: Patient+ | UK Guidelines | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Smallpox Vaccination
See also or record on Smallpox.
Edward Jenner (1749-1823) published work in 1798 entitled "An enquiry into the causes and effects of the variolae vaccinae". This work was done following earlier observations that dairymaids and cowmen did not catch smallpox although they did catch cowpox. Benjamin Jesty (1737-1816) protected his family in a similar way before Jenner reported the first scientific attempt at immunization from a hut near his home in Berkeley, Gloucestershire. Jenner scratched material from a cowpox pustule into the arm of a young local boy, James Phipps, who subsequently developed a pustule and a fever. He remained healthy when subsequently Jenner inoculated him with smallpox. "Vaccinae" means "of the cow" and "vaccination" means "protection from smallpox". At this time there were 23,000 deaths per year from smallpox in England many more across Europe. The case fatality rate was between 20% and 60%.
In 1853 compulsory smallpox vaccination was introduced and in December 1979 the Global Commission for the certification of Smallpox eradication declared the world free of smallpox. In 1980 this was ratified by the World Health Assembly.1 There is now no indication for routine smallpox vaccination.
Smallpox is caused by the variola virus, a DNA virus, humans being the only known reservoir for the disease. It is spread by person to person contact with an incubation period of 10 to 14 days. The overall mortality is about 30%.
The most widely used virus used for smallpox inoculation is vaccinia (derived from the genus Orthopoxvirus). This is a double stranded DNA virus sharing antigenicity with the variola virus usually prepared from calf lymph. Research is underway using recombinant DNA techniques to find a safer vaccine without replication of the vaccinia virus. Current vaccines give protection for 5 years (partial immunity for 10 years or more) with 95%conversion rate after primary vaccination and some protection if given within a few days of exposure. It is administered by multiple skin puncture using a bifurcated needle containing small quantities of the vaccine. A papule develops after 3-5 days and becomes vesicular and pustular over 8-10 days followed by scab and scar formation.2
Smallpox vaccine is less safe than other vaccines used routinely today. A third of recipients get mild vaccine related symptoms. More serious reactions occur infrequently: death (1/million vaccinations); eczema vaccinatum (39/million vaccinations); progressive vaccinia (1.5/million vaccinations); post vaccinial encephalitis (12/million vaccinations); and generalized vaccinia (241/million vaccinations).2
Risk factors
Risk factors for complications and adverse effects include eczema, any conditions disrupting the epidermis (acne, psoriasis, burns, seborrhoeic dermatitis etc), the immunocompromised, immunosuppressed patients, pregnancy, and children under 1 year.2
There is no indication for smallpox vaccination except for:
- Workers in laboratories where pox viruses are handled and others whose work involves an identifiable risk of exposure to pox virus.
Concerns have been expressed about smallpox in relation to bio-terrorism and the availability of vaccine when half of the world's population is unvaccinated.3
- If wider use of vaccine being considered see "Guidelines for smallpox response and management in the post-eradication era".4
- For further advice and guidance for laboratory staff see Advisory Committee on Dangerous Pathogens and Advisory Committee on Genetic Modification 1990. HMSO ISBN 011885450.
- Advice on the need for vaccination and contraindications from the PHLS Virus Reference Division telephone 020 8200 4400.
When required vaccine can be obtained from:
- PHLS on 020 8200 4400
Document references
- Riedel S; Edward Jenner and the history of smallpox and vaccination.; Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21-5.
- Belongia EA, Naleway AL; Smallpox vaccine: the good, the bad, and the ugly. Clin Med Res. 2003 Apr;1(2):87-92. [abstract]
- Arita I; Smallpox vaccine and its stockpile in 2005. Lancet Infect Dis. 2005 Oct;5(10):647-52. [abstract]
- DoH Guidelines for smallpox response and management in the post-eradication era (smallpox plan)
DocID: 409
Document Version: 1
DocRef: bgp25012
Last Updated: 22 Oct 2007
Review Date: 21 Oct 2008
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineMedical reference articles in PatientPlus related to this topic (^ top of page)
Notifiable Diseases
SmallpoxUK guidelines related to this topic (^ top of page)
Guidelines on SmallpoxOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
View current health newsMedical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)


Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

